Jason Baumgartner of BEKHealth Talks About The Current State of Research Operations in a COVID World
Jason Baumgartner, a graduate from Duke University, both undergrad and MBA, has established a successful career in the world of clinical trials and drug development. In 2017 Jason founded BEKHealth Corporation. #BEKHealth Corporation has advanced solutions working with health systems and their electronic medical records to support and facilitate clinical research.
Jason talks with us today about the current state of research operations in a #COVID19 world. How COVID has impacted researcher capacity. How technology is improving patient pre-screening and enrollment . How sites can implement new #technologies to alleviate manual processes and see more patients.
http://www.bekhealth.com/
Видео Jason Baumgartner of BEKHealth Talks About The Current State of Research Operations in a COVID World канала To Be Frank
Jason talks with us today about the current state of research operations in a #COVID19 world. How COVID has impacted researcher capacity. How technology is improving patient pre-screening and enrollment . How sites can implement new #technologies to alleviate manual processes and see more patients.
http://www.bekhealth.com/
Видео Jason Baumgartner of BEKHealth Talks About The Current State of Research Operations in a COVID World канала To Be Frank
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Clinical Trials and Research News Weekly Roundup | 02-10-2020 S2 E06Clinical Trials and Research News Weekly Roundup | 10-28-2019 S1 E15Clinical Trials and Research News Weekly Roundup | S2 E20Teresa Quattrin Speaks About Clinical Trials In A Novel Way: A Children's Story Book | S2 | E03Clinical Trials and Research News Weekly Roundup | S2 E16Clinical Trials and Research News Weekly Roundup | 7-27-2019 S1 E6 | NeurodegenerativeDr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases.Trump Sends Media Into Frenzy With Claims That Rfk Jr. Is A Democratic 'plantClinical Trials and Research News Weekly Roundup | 7-20-2019 S1 E5 | Hidradenitis SuppurativaInterview with Dr. Michael Weiner about Alzheimer's Disease | S2 E08Dr. Robert Jeanfreau Discusses the Impact of COVID-19 on Clinical Investigational Sites | PodcastRich Horgan: Why he Started "Cure Rare Disease" and Their Investigation in Customized TherapiesThe Watchlist Series: David Vs Goliath, An Interview With Patrick Girondi | S1 - E04Investor Watch Series | Funding- Who to Watch | S1 E1The Watchlist Series: Hope And Reality, The ongoing Coronavirus Story | S1 E08Clinical Trials and Research News Weekly Roundup | S2 E10Interview with Dr. Laurence Heifetz About Telehealth for Cancer Patients in Rural America | S2 E11Controversial Clinical Trial Requires Patients Pay $1M | S1 - E02Special Edition: Coronavirus RundownDr. Abribat talks Amolyt Pharma: Advance therapeutic peptides treat endocrine and metabolic diseases